NCT04843020View on ClinicalTrials.gov

ION-682884 in Patients With TTR Amyloid Cardiomyopathy

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 30, 2025

Study Completion Date

December 31, 2025

Conditions

Transthyretin Amyloid Cardiopathy

Interventions

DRUG

ION 682884

Subcutaneous injection every month

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER